Press Releases | Medtronic

Month Year

Email alerts

Mar 4, 2013

Medtronic Seeking Long-Distance Runners Who Benefit from Medical Technology

"Global Heroes" Will Receive Entry and Travel to the Medtronic Twin Cities Marathon or Medtronic TC 10 Mile in October

MINNEAPOLIS - March 4, 2013 - Medtronic, Inc. (NYSE: MDT) announced today it is recruiting runners from around the world who benefit from medical technology to participate in the eighth annual...
Feb 28, 2013

Medtronic Announces CE Mark for Engager(TM) Transcatheter Valve

New Valve Provides Transapical Option for Physicians Treating Patients with Aortic Stenosis

MINNEAPOLIS - February 28, 2013 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européenne) Mark of the Engager Transcatheter Aortic Valve Implantation (TAVI) System with...
Feb 28, 2013

Medtronic EVP & President Chris O'Connell to Speak at Cowen Healthcare Conference

MINNEAPOLIS - Feb. 28, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 33rd Annual Healthcare...
Feb 27, 2013

Meta-Analysis Demonstrates Efficacy of Pillar Procedure for the Treatment of Snoring and Mild to Moderate Obstructive Sleep Apnea

Authors Reach Conclusions After a Meta-Analysis of 7 Clinical Studies for Snoring, and 7 Studies for OSA

MINNEAPOLIS - Feb. 27, 2013 - In a meta-analysis of seven studies published in the January issue of Laryngoscope, Ji Ho Choi, M.D., Ph. D., and coauthors conclude that the Medtronic Pillar...
Feb 26, 2013

Medtronic Gains First FDA Approval to Conduct Early Feasibility Medical Device Study

Shared Commitment to Innovation Enables Early Study of Novel Native Outflow Tract Transcatheter Pulmonary Valve in Patients with Pulmonary Valve Failure

MINNEAPOLIS - February 26, 2013 - Medtronic, Inc. (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval to conduct an early feasibility study using the...
Feb 25, 2013

FDA Approves Longer Lengths of Medtronic's Resolute Integrity Stent

New Sizes of Implantable Medical Device Target Long Coronary Lesions Common Among Diabetes Patients

MINNEAPOLIS -- Feb. 25, 2013 -- Expanding the applicability of its marquee product for the interventional treatment of coronary artery disease in the United States, Medtronic, Inc. (NYSE: MDT)...
Feb 25, 2013

Medtronic CFO Gary Ellis to Speak at Citi Global Healthcare Conference

MINNEAPOLIS - Feb. 25, 2013 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Citi Global Healthcare Conference on...
Feb 19, 2013

Medtronic Reports Third Quarter Earnings

Revenue of $4.0 Billion Grew 4% on a Constant Currency Basis; 3% as Reported

MINNEAPOLIS - February 19, 2013 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2013, which ended January 25, 2013. The Company reported...
Feb 14, 2013

Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2013

MINNEAPOLIS - February 14, 2013 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.26 per share of the Company's common stock. The dividend is payable on...
Feb 13, 2013

Medtronic Announces FDA Approval and Launch of Its Advisa MRI Pacemaker System

Second-generation MR-Conditional Pacemaker Combines Advanced Pacing Technology with MRI Access

MINNEAPOLIS - February 13, 2013 - Showcasing its leadership position in pacing technologies, Medtronic, Inc. (NYSE: MDT), today announced the U.S. Food and Drug Administration (FDA) approval and...

Show per page

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa